EurekAlert! provides eligible reporters with free access to embargoed and breaking news releases.
Eligibility GuidelinesEurekAlert! offers eligible public information officers paid access to a reliable news release distribution service.
Eligibility Guidelines
EurekAlert! is a service of the American Association for the Advancement of Science.
Dana-Farber Cancer Institute
Dr. Joyce Liu talks about her clinical trial showing drug combination may be effective in recurrent ovarian cancer.
Dana-Farber Cancer Institute
None
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.
